Ian S. Patten

Ian S. Patten

Auto-generated profile, based on publicly available information

Ian S. Patten

Department of Orthopaedic Surgery (B.Z, I.P., A.J., J.H.W., and J.R.F.) and Russell H. Morgan Department of Radiology (N.H.N., A.H.M., and S.D.), Johns Hopkins University, Baltimore, Maryland

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2012 in Nature
Verified
Journal Article
Open access
PDF file
IPIan S. Patten
Ian S. Patten
SRSarosh Rana
Sarosh Rana
SSSajid Shahul
Sajid Shahul
GRGlenn C. Rowe
Glenn C. Rowe
CJCholsoon Jang
Cholsoon Jang
ZAZoltan Arany
Zoltan Arany
Peripartum cardiomyopathy (PPCM) is an often fatal disease that affects pregnant women who are near delivery, and it occurs more frequently in women with pre-eclampsia and/or multiple gestation. The aetiology of PPCM, and why it is associated with pre-eclampsia, remain unknown. Here we show that PPCM is associated with a systemic angiogenic imbalance, accentuated by pre-eclampsia. Mice that lack cardiac PGC-1α, a powerful regulator of angiogenesis, develop profound PPCM. Importantly, the PPCM is entirely rescued by pro-angiogenic therapies. In humans, the placenta in late gestation secretes VEGF inhibitors like soluble FLT1 (sFLT1), and this is accentuated by multiple gestation and pre-eclampsia. This anti-angiogenic environment is accompanied by subclinical cardiac dysfunction, the extent of which correlates with circulating levels of sFLT1. Exogenous sFLT1 alone caused diastolic dysfunction in wild-type mice, and profound systolic dysfunction in mice lacking cardiac PGC-1α. Finally, plasma samples from women with PPCM contained abnormally high levels of sFLT1. These data indicate that PPCM is mainly a vascular disease, caused by excess anti-angiogenic signalling in the peripartum period. The data also explain how late pregnancy poses a threat to cardiac homeostasis, and why pre-eclampsia and multiple gestation are important risk factors for the development of PPCM.

8 October 2009 in Blood
Verified
Journal Article
Open access
PDF file
BZBing-Qiao Zhao
Bing-Qiao Zhao
Anil K. ChauhanAnil K. Chauhan
Anil K. Chauhan
MCMatthias Canault
Matthias Canault
IPIan S. Patten
Ian S. Patten
JYJanie J. Yang
Janie J. Yang
DWDenisa D. Wagner
Denisa D. Wagner
Stroke is a leading cause of death and disability. The only therapy available is recombinant tissue plasminogen activator, but side effects limit its use. Platelets play a crucial role during stroke, and the inflammatory reaction promotes neurodegeneration. von Willebrand factor (VWF), an adhesion molecule for platelets, is elevated in patients with acute stroke. The activity of VWF is modulated by ADAMTS13 (a disintegrin-like and metalloprotease with thrombospondin type I repeats-13) that cleaves VWF to smaller less-active forms. We recently documented that ADAMTS13 negatively regulates both thrombosis and inflammation. We report that deficiency or reduction of VWF reduces infarct volume up to 2-fold after focal cerebral ischemia in mice, thus showing the importance of VWF in stroke injury. In contrast, ADAMTS13 deficiency results in larger infarctions, but only in mice that have VWF. Importantly, infusion of a high dose of recombinant human ADAMTS13 into a wild-type mouse immediately before reperfusion reduces infarct volume and improves functional outcome without producing cerebral hemorrhage. Furthermore, recombinant ADAMTS13 did not enhance bleeding in a hemorrhagic stroke model. Our findings show the importance of VWF in regulating infarction and suggest that recombinant ADAMTS13 could be considered as a new therapeutic agent for prevention and/or treatment of stroke.

24 July 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GRGlenn C. Rowe
Glenn C. Rowe
RERiyad El-Khoury
Riyad El-Khoury
IPIan S. Patten
Ian S. Patten
PRPierre Rustin
Pierre Rustin
ZAZolt Arany
Zolt Arany
Exercise confers numerous health benefits, many of which are thought to stem from exercise-induced mitochondrial biogenesis (EIMB) in skeletal muscle. The transcriptional coactivator PGC-1α, a potent regulator of metabolism in numerous tissues, is widely believed to be required for EIMB. We show here that this is not the case. Mice engineered to lack PGC-1α specifically in skeletal muscle (Myo-PGC-1αKO mice) retained intact EIMB. The exercise capacity of these mice was comparable to littermate controls. Induction of metabolic genes after 2 weeks of in-cage voluntary wheel running was intact. Electron microscopy revealed no gross abnormalities in mitochondria, and the mitochondrial biogenic response to endurance exercise was as robust in Myo-PGC-1αKO mice as in wildtype mice. The induction of enzymatic activity of the electron transport chain by exercise was likewise unperturbed in Myo-PGC-1αKO mice. These data demonstrate that PGC-1α is dispensable for exercise-induced mitochondrial biogenesis in skeletal muscle, in sharp contrast to the prevalent assumption in the field.

1 February 2012 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
IPIan S. Patten
Ian S. Patten
ZAZolt Arany
Zolt Arany

12 September 2008 in Circulation Research
Verified
Journal Article
Closed access
PDF file
JKJanka Kisucka
Janka Kisucka
Anil K. ChauhanAnil K. Chauhan
Anil K. Chauhan
IPIan S. Patten
Ian S. Patten
AYAyce Yesilaltay
Ayce Yesilaltay
CNCarola Neumann
Carola Neumann
DWDenisa D. Wagner
Denisa D. Wagner
The peroxiredoxin (Prdx) family of antioxidant enzymes uses redox-active cysteines to reduce peroxides, lipid hydroperoxides, and peroxynitrites. Prdx1 is known to be important to protect red blood cells against reactive oxygen species and in tumor prevention. In this study, the role of Prdx1 in inflammation, thrombosis, and atherosclerosis was investigated. Using intravital microscopy, we showed that the number of leukocytes rolling per minute in unstimulated veins was increased by 2.5-fold in Prdx 1 −/− compared to Prdx 1 +/+ mice. In Prdx 1 −/− mice, 50% of leukocytes rolled at a velocity <10 μm/sec compared with 10% in Prdx 1 +/+ mice, suggesting that adhesion molecule density on the endothelium may have been increased by Prdx1 deficiency. Indeed, endothelial P-selectin, soluble P-selectin, and von Willebrand factor in plasma were increased in Prdx 1 −/− mice compared to Prdx 1 +/+ mice, indicating elevated Weibel–Palade body release. In contrast to this excessive endothelial activation, Prdx 1 −/− platelets showed no sign of hyperreactivity, and their aggregation both in vitro and in vivo was normal. We also examined the role of Prdx1 in the apoE −/− murine spontaneous model of atherosclerosis. Prdx 1 −/− / apoE −/− mice fed normal chow developed larger, more macrophage-rich aortic sinus lesions than Prdx 1 +/+ / apoE −/− mice, despite similar amounts and size distributions of cholesterol in their plasma lipoproteins. Thus, Prdx1 protects against excessive endothelial activation and atherosclerosis, and the Prdx 1 −/− mice could serve as an animal model susceptible to chronic inflammation.

15 August 2014 in Circulation Research
Verified
Journal Article
Closed access
PDF file
GRGlenn C. Rowe
Glenn C. Rowe
SRSrilatha Raghuram
Srilatha Raghuram
CJCholsoon Jang
Cholsoon Jang
JNJanice A. Nagy
Janice A. Nagy
IPIan S. Patten
Ian S. Patten
ZAZolt Arany
Zolt Arany
Rationale : Mechanisms of angiogenesis in skeletal muscle remain poorly understood. Efforts to induce physiological angiogenesis hold promise for the treatment of diabetic microvascular disease and peripheral artery disease but are hindered by the complexity of physiological angiogenesis and by the poor angiogenic response of aged and patients with diabetes mellitus. To date, the best therapy for diabetic vascular disease remains exercise, often a challenging option for patients with leg pain. Peroxisome proliferation activator receptor-γ coactivator-1α (PGC-1α), a powerful regulator of metabolism, mediates exercise-induced angiogenesis in skeletal muscle. Objective : To test whether, and how, PGC-1α can induce functional angiogenesis in adult skeletal muscle. Methods and Results : Here, we show that muscle PGC-1α robustly induces functional angiogenesis in adult, aged, and diabetic mice. The process involves the orchestration of numerous cell types and leads to patent, nonleaky, properly organized, and functional nascent vessels. These findings contrast sharply with the disorganized vasculature elicited by induction of vascular endothelial growth factor alone. Bioinformatic analyses revealed that PGC-1α induces the secretion of secreted phosphoprotein 1 and the recruitment of macrophages. Secreted phosphoprotein 1 stimulates macrophages to secrete monocyte chemoattractant protein-1, which then activates adjacent endothelial cells, pericytes, and smooth muscle cells. In contrast, induction of PGC-1α in secreted phosphoprotein 1 −/− mice leads to immature capillarization and blunted arteriolarization. Finally, adenoviral delivery of PGC-1α into skeletal muscle of either young or old and diabetic mice improved the recovery of blood flow in the murine hindlimb ischemia model of peripheral artery disease. Conclusions : PGC-1α drives functional angiogenesis in skeletal muscle and likely recapitulates the complex physiological angiogenesis elicited by exercise.